Influence of perfluorohexyloctane on tear film and higher order aberrations

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030660

Enrollment

250

Registered

2023-02-02

Start date

2023-02-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H52.7

Interventions

Group 1: Application of perfluorohexyloctane (F6H8), 4 times daily, 4 weeks Group 2: control group - no treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: healthy, untreated eyes

Exclusion criteria

Exclusion criteria: other eye diseases

Design outcomes

Primary

Measure	Time frame
Higher order aberrations (HoA) in RMS (root mean square)	—

Secondary

Measure	Time frame
Measurement accuracy	—

Countries

Germany

Contacts

Public ContactAndreas Frings

Augenheilkunde und Augenlaser Zentrum

augenarzt-frings.de+4991123555825

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026